Form 4: Spruce Biosciences Executive Chairman's Option Repricing

Spruce Biosciences' Executive Chairman, Michael G. Grey, reported changes in his stock option holdings following a reverse stock split and a company-wide option repricing.

Summary

• Michael G. Grey, Executive Chairman and Director of Spruce Biosciences, Inc. (SPRB), reported changes in his beneficial ownership of stock options.
• The changes are primarily due to a reverse stock split and a subsequent stock option repricing.
• Effective August 4, 2025, Spruce Biosciences effected a 1-for-75 reverse stock split, combining every seventy-five shares of common stock into one share.
• In connection with the reverse split, each stock option to purchase 75 shares was automatically combined into an option to purchase one share, and the exercise prices were multiplied by seventy-five.
• A one-time stock option repricing (the "Option Repricing") was effective on December 11, 2025, applying to options with exercise prices of $106.09 per share or greater held by eligible employees and directors.
• Pursuant to the Option Repricing, the exercise price of the repriced options was reduced to $104.13 per share, which was the thirty-day trailing volume-weighted average price of the Common Stock on the Nasdaq Capital Market on the Repricing Date.
• A retention period of one year applies to the repriced options; if an optionholder exercises a repriced option before the end of this period, they will be required to pay the original (higher) exercise price per share.
• No other changes were made to the repriced options, including vesting schedules, expiration dates, or the number of shares underlying them.
• Following these transactions, Michael G. Grey beneficially owns options to purchase a total of 4,340 shares of Common Stock, all with an exercise price of $104.13 per share.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive for the executive due to the reduced option exercise price, which enhances the potential value of their equity compensation. For the company, it's neutral to slightly negative, as a reverse split often signals past stock underperformance, though the repricing aims to re-incentivize management.

Positives

• The option repricing reduces the exercise price for eligible stock options to $104.13 per share, potentially increasing the in-the-money value for the Executive Chairman and other employees/directors.
• The repricing serves as a retention tool for key personnel by making their equity compensation more attractive.

Negatives

• The need for a reverse stock split (1-for-75) often indicates a significantly low share price, which can be a negative signal regarding company performance or market perception.
• The retention period for repriced options, requiring payment of the original higher exercise price if exercised within one year, adds a condition that limits immediate benefit.

Risks

• The retention period for repriced options means that the full benefit of the lower exercise price is contingent on continued service for at least one year, or specific circumstances allowing earlier exercise at the lower price.
• A reverse stock split, while potentially increasing per-share price, does not fundamentally change the company's market capitalization or underlying value and can sometimes be followed by further stock price declines.

Future Outlook

The filing does not provide forward-looking statements regarding the company's financial performance or strategic direction, focusing solely on the mechanics and impact of the reverse stock split and option repricing on executive compensation.

Management Comments

• The Option Repricing applies to options with exercise prices of $106.09 per share or greater held by employees and directors of the Issuer who remained in continuous service with the Company as of the Repricing Date.
• Pursuant to the Option Repricing, the exercise price of the repriced options has been amended to reduce the exercise price to $104.13 per share, the thirty (30)-day trailing volume-weighted average price of the Common Stock on the Nasdaq Capital Market on the Repricing Date.
• If an optionholder exercises a repriced option before the end of a retention period of one year (which period may be shorter in certain circumstances), such optionholder will be required to pay the original exercise price per share of such repriced option.

Industry Context

Reverse stock splits are often undertaken by companies, particularly in the biotechnology sector, to meet minimum stock price requirements for exchange listing or to make shares more attractive to institutional investors. Option repricings are also common in industries where stock performance has lagged, serving as a tool to re-incentivize and retain key talent by restoring the value of their equity compensation.

Comparison to Industry Standards

• Reverse stock splits are a common mechanism for companies, especially in the biotech sector, to regain compliance with exchange listing requirements (e.g., Nasdaq's minimum bid price rule). For example, companies like Sorrento Therapeutics and Athersys have also executed reverse splits to address similar issues.
• Option repricings are a recognized, albeit sometimes controversial, practice in corporate compensation, particularly when a company's stock price has significantly declined, rendering existing options out-of-the-money. This practice aims to restore the incentive value of options for employees and executives, similar to actions taken by companies such as Zynga (in 2012) or Groupon (in 2013) during periods of stock underperformance. The inclusion of a retention period, as seen here, is a common safeguard to ensure continued service.

Corporate Governance

Related Party Transactions

• The stock option repricing is a transaction involving an executive officer and director (Michael G. Grey), which is considered a related party transaction as it directly impacts his compensation.

Stakeholder Impact

• Shareholders: The reverse stock split reduces the number of outstanding shares, increasing the per-share price but not the total value of their holdings. The option repricing could be viewed as a cost or dilution, but also as a necessary step to retain key management.
• Employees/Directors (Optionholders): Those with eligible options benefit from a reduced exercise price, making their options more valuable and providing a renewed incentive for performance and retention.

Next Steps

• The Executive Chairman will continue to hold the repriced stock options, subject to their vesting schedules and the one-year retention period for the repriced exercise price.
• The company will continue to operate under the new share structure resulting from the reverse stock split.

Key Dates

Keywords

Spruce Biosciences, SPRB, Form 4, stock options, option repricing, reverse stock split, executive compensation, insider transaction, corporate governance